Test your candidates in a more physiologically relevant in vitro system

Antibody Analytics have developed a model assay system which mimics the T cell status observed in cancer settings. Using our exhausted T cell model, we can help you determine how well your therapeutic candidates will perform in a more challenging system, where the T cells are phenotypically and functionally akin to those found in the tumor micro-environment.

Want to learn more about our Exhausted T Cell model? Contact one of our team now to see how we can help

What is T cell Exhaustion?

T cell exhaustion is a phenotypic and functional state of a T cell. It is characterised by increased cell surface expression of checkpoint inhibitors and a reduced functional capacity.

Exhausted T cells exhibit reduced proliferation, a reduction in cytokine production and function. In the presence of repeated antigenic stimulation in the context of chronic infection or cancer, increasing numbers of T cells reach this exhausted state and are less able to perform their intended anti-viral or anti-tumor functions.

How does our Exhausted T cell model work?

1. T cells are isolated from PBMCs and are stimulated in culture via CD3 and CD28.

2. Repeated stimulations produce T cells which exhibit sustained up-regulation of multiple checkpoint inhibitors PD-1, TIM-3, LAG-3, CTLA-4, BTLA and the transcription factor TOX

3. These cells are not anergic but are comparatively less proliferative, cytotoxic and able to produce IFNγ and IL-2 than resting T cells

4. In the presence of your therapeutic candidate, the exhausted T cells can be plugged into a functional assay of your choice; T cell cytotoxicity, T cell activation or mixed lymphocyte reactions

Exhausted T Cell Assay
Talk to one of our team to discuss how we could meet your Exhausted T Cell Assay requirements
Click the button below to schedule a meeting with one of our team to see how we can assist you with your Exhausted T Cell needs
Talk to our team

How are customer’s using the T cell exhaustion assay? 

Although a key target for immune checkpoint blockade, exhausted T cell phenotypes are not well comprehended from a therapeutic point of view. 

exhausted t cell assay

Immuno-oncology-based developers are looking to understand the pathways and molecular signatures governing the T cell exhaustion, in an effort to restore anti-tumour immunity. 

Customers use our exhausted T cell exhaustion platforms to determine whether their therapeutic candidates can rescue or revitalize the functionality of the T cells in our human in vitro model, or when they are assessing their candidate’s ability to halt the progression of exhaustion, whereby their molecules are present during the in vitro exhaustion process. 

In both approaches the T cells are phenotypically assessed by flow cytometry for expression of exhaustion markers, activation markers and any others deemed relevant to the mode of action of the customer’s molecules. Changes in cytokine production, proliferative response and functionality are all assessed to give the customer a clear understanding of how their molecule interacts and functions within a compromised tumour microenvironment model albeit an in vitro one. 

Working with us

Although every project is different, here at Antibody Analytics we have built a systematic approach to delivering complex customer studies while keeping the customer’s research needs at the heart of our assay set ups. Our T cell exhaustion methods have been standardized to allow our customers to insert their molecules into a method which is able to answer their developability and functional questions routinely and consistently. Alternatively, we can create a bespoke set up which is unique to you and the challenges you face. 

If you are looking to test your molecule in a more predictable, standardized method, why not share some of your requirements in the form below and we can get a proposal out to you, or alternatively speak to our team and let us build a tailored approach to just for you.  

Got a Question?
Other Assays you may be interested in


In a results-driven manner, our expert immunologists can work with you to develop further immunological assays to interrogate the data arising from the cytokine release assay.


Our assay is readily adaptable to address your scientific questions. The T cell population to be suppressed can be selected from PBMCs, pan-T cells, CD4+ or CD8+ T cells as required.


MLR assays can take a variety of formats that should first be defined and optimised based on the requirements and the endpoints of the assay.


Our capabilities allow us to support early screening activities all the way through to the development of lot release potency assay methods.

Stay in touch with our R&D in this space and request further info